Oncomatryx Biopharma S.l.

This early-stage trial is testing a new drug called OMTX705, both alone and combined with existing immunotherapy drugs, for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find the safest dose and see if the treatment shows…

This early-stage trial is testing a new drug called OMTX705, given alongside standard chemotherapy and an immunotherapy drug, for people with advanced pancreatic cancer that has spread. The main goal is to find a safe dose and see how well the body tolerates the combination. Rese…